Alector, Inc. financial data

Symbol
ALEC on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
131 Oyster Point Blvd., Suite 600, South San Francisco, CA
Fiscal year end
December 31
Former names
Alector LLC (to 9/16/2015)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 337 % -39.3%
Debt-to-equity 302 % +5.84%
Return On Equity -109 % -45.5%
Return On Assets -27 % -39.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 97.9M shares +16.4%
Common Stock, Shares, Outstanding 97.9M shares +16.4%
Entity Public Float 384M USD -38.8%
Common Stock, Value, Issued 9K USD +12.5%
Weighted Average Number of Shares Outstanding, Basic 97.5M shares +16.2%
Weighted Average Number of Shares Outstanding, Diluted 97.5M shares +16.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 61.5M USD -36.1%
Research and Development Expense 187M USD -5.87%
General and Administrative Expense 59.5M USD +4.12%
Operating Income (Loss) -185M USD -16%
Income Tax Expense (Benefit) 1.75M USD -59.1%
Net Income (Loss) Attributable to Parent -158M USD -12%
Earnings Per Share, Basic -1.71 USD/shares -0.59%
Earnings Per Share, Diluted -1.71 USD/shares -0.59%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37.2M USD -63.6%
Marketable Securities, Current 420M USD -13.7%
Assets, Current 469M USD -23.5%
Property, Plant and Equipment, Net 18.2M USD -21.2%
Operating Lease, Right-of-Use Asset 20.8M USD -20.1%
Other Assets, Noncurrent 6.09M USD -28.8%
Assets 516M USD -23.3%
Accounts Payable, Current 5.02M USD +7.22%
Employee-related Liabilities, Current 15.3M USD +19.9%
Accrued Liabilities, Current 25.7M USD -15.5%
Contract with Customer, Liability, Current 55.4M USD -31.2%
Liabilities, Current 143M USD -8.29%
Contract with Customer, Liability, Noncurrent 193M USD -16.1%
Operating Lease, Liability, Noncurrent 26M USD -18.5%
Other Liabilities, Noncurrent 1.23M USD +37.4%
Liabilities 397M USD -22.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 931K USD
Retained Earnings (Accumulated Deficit) -827M USD -23.7%
Stockholders' Equity Attributable to Parent 119M USD -26.8%
Liabilities and Equity 516M USD -23.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -61.3M USD -26.4%
Net Cash Provided by (Used in) Financing Activities 71.1M USD +6490%
Net Cash Provided by (Used in) Investing Activities -11.8M USD -113%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 97.9M shares +16.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2M USD -105%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 38.7M USD -62.6%
Deferred Tax Assets, Valuation Allowance 205M USD +24.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Deferred Tax Assets, Gross 215M USD +22.2%
Operating Lease, Liability 38.9M USD -10.2%
Payments to Acquire Property, Plant, and Equipment 533K USD -48%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -157M USD -15.8%
Lessee, Operating Lease, Liability, to be Paid 48.5M USD -14%
Property, Plant and Equipment, Gross 49.9M USD +3.69%
Operating Lease, Liability, Current 8.68M USD +3.46%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.16M USD +4.91%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.86M USD +4.97%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.56M USD -26.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.48M USD +4.87%
Deferred Tax Assets, Operating Loss Carryforwards 12.4M USD -40.6%
Unrecognized Tax Benefits 20.2M USD +33.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.8M USD +4.82%
Additional Paid in Capital 945M USD +13.6%
Deferred Tax Assets, Net of Valuation Allowance 10.4M USD -10.5%
Share-based Payment Arrangement, Expense 40.8M USD -3.38%